A detailed history of Amalgamated Bank transactions in Nkarta, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,125 shares of NKTX stock, worth $2,643. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,125
Previous 1,125 -0.0%
Holding current value
$2,643
Previous $7,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$5.59 - $15.71 $9,044 - $25,418
-1,618 Reduced 58.99%
1,125 $12,000
Q4 2023

Feb 06, 2024

SELL
$1.31 - $6.6 $438 - $2,211
-335 Reduced 10.88%
2,743 $18,000
Q2 2023

Aug 11, 2023

SELL
$2.19 - $5.17 $648 - $1,530
-296 Reduced 8.77%
3,078 $6,000
Q1 2023

May 02, 2023

SELL
$3.37 - $6.3 $2,463 - $4,605
-731 Reduced 17.81%
3,374 $12,000
Q2 2022

Aug 15, 2022

BUY
$7.77 - $19.44 $18,702 - $46,792
2,407 Added 141.76%
4,105 $51,000
Q1 2022

Jun 30, 2022

BUY
$8.66 - $14.99 $14,704 - $25,453
1,698 New
1,698 $19,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $114M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.